Skip to main content

Syra Health Corp (SYRA)

Sector
Healthcare
Industry
Medical Care Facilities
Last price
$0.56
As of

Kresmion compiles this page from SYRA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Syra Health Corp (SYRA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-03.

As of . Source: SEC EDGAR filings for SYRA. Method and limitations.

COMPANY DOSSIER

See the full SYRA dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for SYRA on one page. Preview it with sample data, then open it live with a free account.

Preview the SYRA dossier

Active events for SYRA

  • mediumEarnings below estimates

    Q1-2024: Missed consensus by 13.5% - EPS $-0.22 vs $-0.1938 estimate

  • mediumEarnings below estimates

    Q4-2023: Missed consensus by 74.3% - EPS $-0.16 vs $-0.0918 estimate

  • mediumEarnings below estimates

    Q2-2024: Missed consensus by 13.5% - EPS $-0.22 vs $-0.1938 estimate

  • mediumEarnings below estimates

    Q2-2024: Missed consensus by 8.4% - EPS $-0.21 vs $-0.1938 estimate

  • mediumEarnings above estimates

    Q3-2024: Beat consensus by 72.0% - EPS $-0.06 vs $-0.2142 estimate

FREE, NO ACCOUNT

Every event on SYRA, as it fires

New filings, 13F moves and cross asset events on SYRA land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, SYRA

Going concern statement

SYRA's 10-Q filed Nov 3, 2026 states:

These factors raise substantial doubt about the Company's ability to continue as a going concern.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on SYRA

SYRA against its peers

SYRA's operating margin of -12.5% ranks in the 50th percentile of 18 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-03-31.

MetricSYRAPeer medianPercentilen
Revenue FY7.2M USD41.4M USD3617
Gross margin34.4%52.0%508
Operating margin-12.5%-10.2%5018
Net margin-12.4%-7.7%3819
Return on equity-42.7%-6.5%359
1 year850.0%-32.6%9717

Peers (19): PIII, ADIA, AMS, CCM, GBCS, BICX, DCGO, EHSI, NIVF, HLYK, RHEP, BTMD, CCEL, AIRS, BMGL, JYNT, CYH, STLN, MCTA. Left out: XCRT (no annual filing), PARK (no annual filing), WW (no annual filing), HWAIF (no annual filing), PAIYY (period gap), AUNA (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (SYRA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in SYRA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on SYRA in the last 180 days.

Upstream: SEC EDGAR filings for SYRA

Kresmion, "Syra Health Corp (SYRA) institutional holdings and SEC filings", data as of 2026-11-03, https://kresmion.com/research/SYRA. Upstream data: SEC EDGAR filings for SYRA.

Link to this data (HTML):

<a href="https://kresmion.com/research/SYRA">Syra Health Corp (SYRA) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow SYRA on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to SYRA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the SYRA dossier
Share

The SYRA intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.